Company
Headquarters: Helsinki, Finland
Employees: 63
CEO: Mr. Teemu Suna
€142.4 Million
EUR as of July 1, 2024
US$153.0 Million
| Company | Market Cap (USD) |
|---|---|
| GE HealthCare | $37.81 B |
| Veeva Systems Inc. | $36.08 B |
| M3, Inc. | $11.14 B |
| Change Healthcare Inc. | $9.03 B |
| Pro Medicus Limited | $8.96 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Nightingale Health Oyj, a health technology company, offers health data platform that detects disease risks. The company's blood analysis technology measures various biomarkers from a single blood sample and identifies personal risks of disease using health data assets. It serves healthcare service providers and direct consumers in Finland, rest of Europe, North America, Asia, and internationally. The company was incorporated in 2002 and is headquartered in Helsinki, Finland.
Nightingale Health Oyj has the following listings and related stock indices.
Stock: OMXH: HEALTH
Stock: FSX: 7XE